Article Text

Download PDFPDF
Expression of an ASCL2 related stem cell signature and IGF2 in colorectal cancer liver metastases with 11p15.5 gain
  1. D E Stange1,2,
  2. F Engel1,
  3. T Longerich3,
  4. B K Koo4,
  5. M Koch2,
  6. N Delhomme1,
  7. M Aigner2,
  8. G Toedt1,
  9. P Schirmacher3,
  10. P Lichter1,
  11. J Weitz2,
  12. B Radlwimmer1
  1. 1Division of Molecular Genetics, German Cancer Research Center (DKFZ), Heidelberg, Germany
  2. 2Department of Surgery, University of Heidelberg, Heidelberg, Germany
  3. 3Institute of Pathology, University of Heidelberg, Heidelberg, Germany
  4. 4Hubrecht Institute, KNAW & University Medical Center Utrecht, Utrecht, The Netherlands
  1. Correspondence to Dr B Radlwimmer, Division of Molecular Genetics, German Cancer Research Center, Im Neuenheimer Feld 280, 69120 Heidelberg, Germany; b.radlwimmer{at}


Background and aims Liver metastases are the leading cause of death in colorectal cancer. To gain better insight into the biology of metastasis and possibly identify new therapeutic targets we systematically investigated liver-metastasis-specific molecular aberrations.

Methods Primary colorectal cancer (pCRC) and matched liver metastases (LMs) from the same patients were analysed by microarray-based comparative genomic hybridisation in 21 pairs and gene expression profiling in 18 pairs. Publicly available databases were used to confirm findings in independent datasets.

Results Chromosome aberration patterns and expression profiles of pCRC and matched LMs were strikingly similar. Unsupervised cluster analysis of genomic data showed that 20/21 pairs were more similar to each other than to any other analysed tumour. A median of only 11 aberrations per patient was found to be different between pCRC and LM, and expression of only 16 genes was overall changed upon metastasis. One region on chromosome band 11p15.5 showed a characteristic gain in LMs in 6/21 patients. This gain could be confirmed in an independent dataset of LMs (n=50). Localised within this region, the growth factor IGF2 (p=0.003) and the intestinal stem cell specific transcription factor ASCL2 (p=0.029) were found to be over-expressed in affected LM. Several ASCL2 target genes were upregulated in this subgroup of LM, including the intestinal stem cell marker OLFM4 (p=0.013). The correlation between ASCL2 expression and four known direct transcriptional targets (LGR5, EPHB3, ETS2 and SOX9) could be confirmed in an independent expression dataset (n=50).

Conclusions With unprecedented resolution a striking conservation of genomic alterations was demonstrated in liver metastases, suggesting that metastasis typically occurs after the pCRC has fully matured. In addition, we characterised a subset of liver metastases with an ASCL2-related stem-cell signature likely to affect metastatic behaviour of tumour cells.

  • Colorectal cancer
  • liver metastasis
  • ASCL2
  • array-CGH
  • expression profiling

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • Linked articles 212241

  • Funding This work was supported by a grant from the Tumorzentrum Heidelberg–Mannheim to BR, TL and PS, and by the platform activities funded by grant 01GS0883 of the Deutsches Bundesministerium für Bildung und Forschung to BR and PL.

  • Competing interests None.

  • Ethics approval This study was conducted with the approval of the Ethics Committee of the University of Heidelberg.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Linked Articles